| INTRODUCTION
Neuropathic pain is a type of chronic pain caused by damage or disease affecting the somatosensory nervous system. 1 The approximate prevalence of neuropathic pain in the gross population is 7%-10%, and more than 20% of cancer pains are neuropathic origin. 2, 3 Although the prevalence is very high, neuropathic pain remains extremely difficult to cure, mainly due to barely understood pathogenesis and a lack of welldefined molecular targets.
MicroRNAs (miRNAs) are a group of gene expression negative regulators which repress gene expression by binding to the 3 0 -untranslated region (UTR) of mRNA directly. miRNAs play important roles in maintaining normal human body physiologic conditions. Abnormal miRNA expressions have been related to human diseases spanning psychiatric disorders to malignant cancers. [4] [5] [6] There are reports indicated that miRNAs play important roles in different states of the neuropathic pain such as disordered miR-132, miR-183, miR-96 and miR-30 in rat models. [7] [8] [9] Alterations in the neuro-immune balance play a major role in the pathophysiology of chronic neuropathic pain. The signaling complex nuclear factor-κB (NF-κB) is a key regulator of molecules and pathways important for inflammation and pain. Emerging evidence indicates that the activation of NF-κB following nerve injury is related to the generation of neuropathic pain. 10, 11 The cytoplasmic-nucleus shuttling of large proteins is a highly regulated process mediated by specific nuclear import systems including importin α and importin β. 12 Proteins containing a lysine-rich or arginine-rich nuclear localization sequence (NLS) are imported by the classical importin α/β heterodimers. There is a report indicates that KPNB1 and KPNA2 participate in the nuclear translocation of p65. 13 Meanwhile, dysregulated KPNB1 has been found relates to neuro-disorders including amyotrophic lateral sclerosis and cerebral ischemia reperfusion injury. 14, 15 In the present study, we found miR-101 was reduced in the plasma and sural nerve biopsies from patients with neuropathic pain.
We identified that miR-101 may functions as an activator of NF-κB signaling through controlling the nuclear translocation of p65 during the pathogenesis of neuropathic pain.
| MATERIALS AND METHODS

| Patients
Patients with neuropathic pain were recruited at the Department of Anesthesia and Surgery, Qingdao Municipal hospital between 2015
and 2017, where they underwent diagnostic work-up, including sural nerve biopsy. The study was approved by the Qingdao Municipal Hospital Ethic Committee and written informed consent was obtained from all the participants before recruitment. The diagnosis of neuropathy was based on characteristic symptoms and signs in the neurological examination and typical findings in the electrophysiological assessment with standard nerve conduction studies in motor and sensory nerves of the upper and lower limbs. 16 Patients with autoimmune, chronic, inflammatory, neoplastic, or psychiatric diseases were excluded.
Neuropathies were classified as painful if the patients reported pain with an intensity of three or more on a numeric rating scale (NRS) ranging from 0 to 10. Patients with score 0 meaning "no pain"
and "10" means pain as "bad as it could be". 17 The control group consisted of healthy volunteers. 
| RNA extraction and quality determination
| Western blotting
Protein extracts were boiled in sodium dodecyl sulfate/β-mercaptoethanol The specific protein-antibody complex was detected by using horseradish peroxidase conjugated rabbit anti-mouse IgG. Detection by the chemiluminescence reaction was carried using ECL kit (Pierce, Appleton, WI). The β-actin signal was used as a total cell lysate loading control. Lamin B1 was used as loading control for nuclear protein and α-tubulin was used as control for cytosol protein. 
| Cell culture
| Dual luciferase assays
To generate 3'-UTR luciferase reporter, a 323 bp segment of KPBN1 
| Elisa
Levels of IL-1β, TNF-α of cell culture supernatants were determined by enzyme-linked immunosorbent assay (ELISA) (eBioscience Inc., San Diego, CA) following the manufacturers' instructions.
| Statistical analyses
Data were analyzed using SPSS Statistical Package version 16 (SPSS Inc., Chicago, IL). Two-tailed Student's t-test was used to calculate statistical significance between the two-comparator groups. The correlation analysis was analyzed by χ 2 -analysis. The findings were considered significant at a P-value <0.05.
| RESULTS
To investigate the roles of miRNAs in the neuropathic pain, we collected the plasma samples from 23 patients with chronic neuropathic pain ( Table 1 ) and 10 healthy controls. Total RNA was extracted from plasma and the expression of six candidate miRNAs, including miR-132, miR-96, miR-146a, miR-101, miR-124, and miR-155 was quantified by quantitative RT-PCR. We chose these miRNAs because the level of those miRNAs had been found disturbed in neuropathic pain models or patients, and related to the pathogenesis of nervous system disorder. 7, 9, 18, 19 We found the level of miR-132 was upregulated and miR-101 was downregulated when compared with healthy control (Figure 1 ). To understand whether the alteration of plasma miRNA level was consistent with the local tissues underwent neuropathic pain, we extracted RNAs from sural nerve biopsies, and detected the miR-132 and miR-101 level. As shown in Figure 2A , the miR-101 expression was also significantly repressed in the nerve samples from neuropathic pain patients.
To further explore the function of miR-101, we predicted the target gene of miR-101 using bioinformatics tools. According to the prediction from TargetScan (http://www.targetscan.org/vert_70/), we found that KPBN1 is a potential target of miR-101, so we constructed reporter vectors containing wildtype or mutant 3'UTR of KPBN1 mRNA ( Figure 2B ). HEK293T cells were transfected with miR-101 mimic or inhibitor with reporter vector. As shown in Figure 2C 
F I G U R E 1
The level of miRNAs was disturbed in the plasma from neuropathic pain patients. Total RNA was extracted from plasma samples from 23 patients with neuropathic pain and 10 healthy controls. The level of six candidate miRNAs was detected by qRT-PCR. Results were analyzed by student's t-test and P < 0.05 was considered as statistically significant direct target of miR-101, and miR-101 repress KPNB1 expression via direct degraded the KPNB1 mRNA level.
To further explore whether miR-101 regulate KPNB1 expression in vivo, total RNA was extracted from sural nerve biopsy and the mRNA level of KPNB1 was examined by qRT-PCR. As KPNB1 is a key regulator for NF-κB/p65 nuclear importing, we proposed that miR-101 reduction may relates to activated NF-κB signaling. So the mRNA level of IL-1β and TNF-α was also examined. As shown in Figure MiR-101 is a multiple function molecule, which has been found play a role in maintaining the homeostasis of the neuro system, and abnormal miR-101 level has been identified relates to pathophysiological conditions including spinocerebellar ataxia type 1 and Alzheimer's disease. 18, 27, 28 miR-101 also functions as an important regulator during the immune response in macrophages. 29 However, roles of miR-101 in the neuroimmune system is still unknown. In this study, we identified that miR-101 functions as a NF-κB signaling inhibitor inhibit p65 nuclear translocation via targeting KPNB1 in the peripheral nerve sheath tumor sNF96.2 cells and the overexpression of IL-1β and TNF-α is also confirmed in the tissue biopsies which partially unveil the roles of miR-101 during the pathogenesis of neuropathic pain.
There are some limitations in our study. Firstly, the upstream molecules of miR-101 remain unclear. Until now, several miR-101 natural negative regulators has been found in human, including EZH2, IL-1β, MALAT1, and NEAT1. EZH2 is a histone H3K27 methyltransferase, which was found to be repressed by miR-101. 30 Meanwhile, as a feedback inhibitor, EZH2 binds to miR-101 promoter region under the F I G U R E 4 miR-101 inhibitor promotes p65 nuclear translocation. sNF96.2 cells were transfected with miR-101 inhibitor for 48 h and then treated by LPS. The level of miR-101 and KPNB1 was detected by qRT-PCR, and level of IL-1β and TNF-α was determined by ELISA. Results were analyzed using student's t-test and P < 0.05 was considered as statistically significant. *P < 0.05, **P < 0.01 help of NDY1. 31 Meanwhile, IL-1β was found promotes lung cancer cells proliferation and migration by repressing miR-101. 32 LncRNAs like MALAT1 and NEAT1 was confirmed function as competing endogenous RNA and directly interact with miR-101. 33, 34 Our further study will analyze the correlation between the level of these miR-101 negative regulators and miR-101, and try to find a clue unveil the mechanism of miR-101 reduction during neuropathic pain. Secondly, one miRNA usually has many direct targets, so miR-101 may be involved in neuropathic pain by targeting several proteins and we did not evaluate all the possible targets of miR-101. Although false positive results existed, argonaute2 co-immunoprecipitation coupling with microarray or high-speed sequencing is still a powerful high throughput method to identify miRNA direct targets. 35 Therefore, our further study may use high throughput method to identify miR-101 targets and investigate their roles during neuropathic pain.
In conclusion, miR-101 reduction contributes to the pathogenesis of neuropathic pain through promoting the activation of NF-κB signaling, which provide a new approach of pain amelioration.
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